Literature DB >> 23733544

Biomarkers and heart disease: what is translational success?

Francis G Spinale, Craig M Stolen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23733544      PMCID： PMC4360982          DOI： 10.1007/s12265-013-9477-9

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


× No keyword cloud information.
  10 in total

Review 1.  ST2 as a cardiovascular risk biomarker: from the bench to the bedside.

Authors:  James L Januzzi
Journal:  J Cardiovasc Transl Res       Date:  2013-04-05       Impact factor: 4.132

Review 2.  Evaluation of heart failure biomarker tests: a survey of statistical considerations.

Authors:  Arkendra De; Kristen Meier; Rong Tang; Meijuan Li; Thomas Gwise; Shanti Gomatam; Gene Pennello
Journal:  J Cardiovasc Transl Res       Date:  2013-05-14       Impact factor: 4.132

3.  Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.

Authors:  Nadezhda Glezeva; Patrick Collier; Victor Voon; Mark Ledwidge; Kenneth McDonald; Chris Watson; John Baugh
Journal:  J Cardiovasc Transl Res       Date:  2013-04-27       Impact factor: 4.132

Review 4.  MicroRNAs as biomarkers for ischemic heart disease.

Authors:  Lucas N L Van Aelst; Stephane Heymans
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

Review 5.  Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

Authors:  Michael R Zile; Catalin F Baicu
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

6.  Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease.

Authors:  Olivier Muller; Argyrios Ntalianis; William Wijns; Leen Delrue; Karen Dierickx; Reto Auer; Nicolas Rodondi; Fabio Mangiacapra; Catalina Trana; Michalis Hamilos; Emmanuel Valentin; Bernard De Bruyne; Emanuele Barbato; Jozef Bartunek
Journal:  J Cardiovasc Transl Res       Date:  2013-05-14       Impact factor: 4.132

Review 7.  Heart failure biomarkers.

Authors:  Rajiv Choudhary; Navaid Iqbal; Fatima Khusro; Erin Higginbotham; Erik Green; Alan Maisel
Journal:  J Cardiovasc Transl Res       Date:  2013-04-20       Impact factor: 4.132

Review 8.  New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.

Authors:  Deepa M Gopal; Flora Sam
Journal:  J Cardiovasc Transl Res       Date:  2013-04-23       Impact factor: 4.132

9.  Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.

Authors:  Rupak Mukherjee; Joseph G Akar; J Marcus Wharton; Deborah K Adams; Catherine D McClure; Robert E Stroud; Allison D Rice; Stacia M DeSantis; Francis G Spinale; Michael R Gold
Journal:  J Cardiovasc Transl Res       Date:  2013-05-31       Impact factor: 4.132

Review 10.  Positioning of inflammatory biomarkers in the heart failure landscape.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  J Cardiovasc Transl Res       Date:  2013-05-11       Impact factor: 4.132
  10 in total
  4 in total

1.  Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT.

Authors:  Hicham Skali; Robert Gerwien; Timothy E Meyer; James V Snider; Scott D Solomon; Craig M Stolen
Journal:  J Cardiovasc Transl Res       Date:  2016-10-31       Impact factor: 4.132

2.  Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis.

Authors:  Yongshi Wang; Boting Wu; Lili Dong; Chunsheng Wang; Xiaolin Wang; Xianhong Shu
Journal:  Heart Vessels       Date:  2014-10-18       Impact factor: 2.037

3.  Myocardial and Peripheral Ischemia Causes an Increase in Circulating Pregnancy-Associated Plasma Protein-A in Non-atherosclerotic, Non-heparinized Pigs.

Authors:  Lasse Bach Steffensen; Christian Bo Poulsen; Jeong Shim; Marie Bek; Kevin Jacobsen; Cheryl A Conover; Jacob Fog Bentzon; Claus Oxvig
Journal:  J Cardiovasc Transl Res       Date:  2015-10-06       Impact factor: 4.132

4.  The influence of exendin-4 intervention on -obese diabetic mouse blood and the pancreatic tissue immune microenvironment.

Authors:  Jinshui He; Chaowei Lian; Yanling Fang; Jinzhi Wu; Huowang Zhou; Xiaoling Ye
Journal:  Exp Ther Med       Date:  2016-09-12       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.